The F.D.A's Center for Devices and Radiological Health designated an invention developed by Dr. Rajah Vijay Kumar as a "breakthrough device" in the treatment of liver, pancreatic, and breast cancers. Gaithersburg, MD-based Shreis Scalene Sciences LLC presented the device to the USFDA which released a communique that said, "We are...
AstraZeneca’s Biliary Tract Cancer Drug Receives Regulatory Approval in India
British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca PLC's India arm announced that it received additional indication approval from the Central Drugs Standard Control Organization (CDSCO) for the drug Durvalumab to treat biliary tract cancer (BTC) in India. BTC is a group of rare and aggressive gastrointestinal cancers that form in the...